Clinical studies have demonstrated elevated levels of both arachidonic acid and prostaglandins in the cerebrospinal fluid of humans after ischemic stroke and subarachnoid hemorrhage. Such increases in free fatty acid, arachidonic acid, and prostaglandin concentrations suggest excessive production and accumulation of these substances in the ischemic brain. We used a rabbit model of ischemic infarction to examine the relation between controlled central nervous system ischemia and cerebrospinal fluid prostaglandin levels. We found that following stroke PGF^ and not PGD 2 was the predominant prostaglandin present in the cerebrospinal fluid. PGF^ also underwent the largest percent increase over control prostaglandin concentrations. This is similar to human and dog cerebrospinal fluid studies, which demonstrate PGF^ as the predominant prostaglandin following ischemic injury. The lack of PGD, elevation under ischemic conditions may suggest that the rabbit model is more like stroke in humans than the rat or gerbil models. Our preliminary work demonstrates that it is practical to study postischemic prostaglandin changes in cerebrospinal fluid rather than in brain tissue in a rabbit model of central nervous system ischemia. (Stroke 1988; 19:349-351)
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Barrett Katz, MD, Mark Sofonio, BS, Patrick D. Lyden, MD, and Murray D. Mitchell, DrPhil Clinical studies have demonstrated elevated levels of both arachidonic acid and prostaglandins in the cerebrospinal fluid of humans after ischemic stroke and subarachnoid hemorrhage. Such increases in free fatty acid, arachidonic acid, and prostaglandin concentrations suggest excessive production and accumulation of these substances in the ischemic brain. We used a rabbit model of ischemic infarction to examine the relation between controlled central nervous system ischemia and cerebrospinal fluid prostaglandin levels. We found that following stroke PGF^ and not PGD 2 was the predominant prostaglandin present in the cerebrospinal fluid. PGF^ also underwent the largest percent increase over control prostaglandin concentrations. This is similar to human and dog cerebrospinal fluid studies, which demonstrate PGF^ as the predominant prostaglandin following ischemic injury. Studies have demonstrated, however, that insults to neural tissue (e.g., trauma, hypoxia, ischemia, subarachnoid hemorrhage) will cause an increase in the amount of free fatty acids in brain tissue. 5 " 8 This is especially true for arachidonic acid (the precursor of prostaglandins E 2 and F^, prostacyclin, and thromboxane A 2 ). The increase in these substances after ischemia is thought to be the result of activation of endogenous Upases (e.g., phospholipases A 2 and C) that hydrolyze cellular phospholipids and lead to the release of membranebound arachidonic acid. 9 Porcellati et al'° and Yoshida et al" reported carotid artery occlusion to cause an increase in the levels of free fatty acids in the gerbil brain. Others have demonstrated an increase in free fatty acid and prostaglandin content in rat and dog brain following hypoxia.
-'
2~14 These elevations of arachidonic acid and prostaglandin concentrations are also reflected in subhuman primate and human cerebrospinal fluid (CSF). Determinations within CSF avoid the artifactual release of arachidonic acid and prostaglandin that occurs following brain dissection and tissue handling. 15 Clinical studies have demonstrated elevated levels of both arachidonic acid and prostaglandins in human CSF following ischemic stroke and subarachnoid hemorrhage.
1416 "' 8 Such increases in free fatty acid, arachidonic acid, and prostaglandin concentrations suggest excessive production and accumu-lation of these substances in the ischemic brain. These substances may serve as markers of central nervous system (CNS) ischemia. We used a rabbit model of ischemic infarction to examine the relation between controlled CNS ischemia and CSF prostaglandin levels.
Materials and Methods
We used two groups of New Zealand white female rabbits: a control group in which to measure baseline CSF prostaglandin levels and an experimental group subjected to stroke. All rabbits were obtained commercially, were > 3 months old, and weighed between 2.5 and 3.0 kg. Rabbits in the experimental group (n = 5) had embolic infarction as reported previously. 19 Briefly, rabbits were anesthetized with 5 mg/kg ketamine (Parke-Davis, Morris Plains, New Jersey) and 35 mg/kg i.m. xylazine (Miles Laboratories, Elkhart, Indiana). The carotid bifurcation was exposed through a lateral neck incision, and the external carotid artery branches were ligated. An arteriotomy was performed on the more lateral branch, and Silastic catheter (0.047 in. i.d., Dow Corning) was inserted, sutured to adjacent tissue, and tunneled through an exit wound behind the ear. Twenty-four hours after surgery, a bolus of 0.1 ml autologous clot (incubated at 37° C for 24 hours) was injected into the catheter, followed by 0.5 ml normal saline. Cerebral infarction was judged to be present if the rabbit demonstrated hemiparesis subsequent to the procedure. Previous study has demonstrated this model to yield reproducible cerebral infarction in the middle cerebral artery territory of 95% of rabbits so embolized. 19 CSF was withdrawn at 20° C from the cisterna magna 6 days after induced stroke. CSF collections were atraumatic and not contaminated by hemorrhage. Samples were frozen immediately without fixation material. Rabbits were killed and their brains were removed for study.
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Stroke Vol 19, No 3, March 1988 A control group of five rabbits was used to establish baseline CSF prostaglandin levels. These rabbits were anesthetized with the same medications and CSF was withdrawn under identical conditions.
Determinations of Prostaglandin Concentrations
Sample sizes were insufficient to allow individual analysis of all prostaglandins, so prior to assay, control samples were pooled and experimental samples were pooled. Prostaglandin F^ (PGE,), PGF^, PGD 2 , 6-keto-PGF la (6KF,J, and thromboxane B 2 (TXB 2 ) were measured by sensitive and specific radioimmunoassays that have been described and validated. 20 " 22 Briefly, samples were extracted into acidified diethyl ether. The organic solvent was evaporated and the residue dissolved in assay buffer. All samples were assayed in duplicate with appropriate standard curves for reference. Water and solvent blanks were included in each assay, and the amounts of prostaglandins in the blanks were negligible in these experiments. Sample extracts, antisera, and appropriate radiolabeled prostaglandins were incubated at 4° C for 3 hours, at which time bound and free radiolabel were separated by use of activated charcoal. Radioactivity was determined using an LKB 1219 radioactivity analyzer (Gaithersburg, Maryland).
Results
All brains in the experimental group were examined. An occluding embolus was identified in the middle cerebral or internal carotid artery of each rabbit. A pale area of infarction was found in all rabbits, encompassing the entire middle cerebral artery territory. Each infarction involved both cortical and subcortical structures.
The control group CSF prostaglandin profile is illustrated (Figure 1 ). The most abundant prostaglandin was PGD 2 (122 pg/ml), followed in concentration by PGF^ (63 pg/ml) and PGE, (38 pg/ml). The 6KF la (a prostacyclin metabolite) concentration was 15 pg/ml, while the TXB 2 concentration was 10 pg/ml.
The prostaglandin concentrations for the experimental group are compared with those from the control group (Figure 1 ). For rabbits subjected to cerebral
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FIGURE 1. Concentration of prostanoids (prostaglandin profile) in cerebrospinal fluid of normal (control) (filled columns) andfocalfy ischemic (experimental) rabbits (hatched columns).
infarction the most abundant prostaglandin was ( 230 pg/ml). This represented an almost fourfold increase over control levels. PGE 2 was also elevated in the experimental group; at 84 pg/ml, this represented a twofold increase over control levels. PGD 2 concentrations were similarly elevated (157 pg/ml), a 30% increase over the control group. Both 6KF lo and TXB 2 were decreased in the experimental compared with the control rabbits. TXB 2 concentration was 7 pg/ml, decreased from 10 pg/ml in the control pool; 6KF lo was not detectable in the stroke pool though initially it was 10 pg/ml in the control pool.
Discussion
Our studies demonstrate that baseline rabbit CSF prostaglandin levels parallel those seen in rat and gerbil brain, with predominance of PGD 2 and lower levels of PGF^, PGE 2 , 6KF la , and TXB,.
2 " 6 Very low levels of 6KF la (a stable metabolite of prostacyclin) were detected. These findings contrast to those seen in dog brain, in which PGD 2 levels are negligible and 6KF ]a levels are high.
1426 Such species differences as well as differences between whole brain preparations and CSF levels have been recognized previously. In human whole brain tissue, PGF^ is the most abundant prostaglandin, followed by PGE;. 2 * Prostacyclin levels are low in whole brain tissue. 26 In contrast, prostacyclin and its stable derivatives are the principal prostaglandins in human CSF.
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- 26 Dogs have similar differences between prostaglandin levels in whole brain tissue and CSF.
14 While whole brain generates PGFâ nd PGEj, it does not produce prostacyclin.
1525 - 26 Rather, endothelial cells, like those found in the choroid plexus, generate prostacyclin.'-2 - 15 Thus, whole brain tissue is typically low in prostacyclin while CSF demonstrates higher concentrations.
All of our experimental rabbits with stroke exhibited large middle cerebral artery infarctions. In this preliminary study no attempt was made to quantify the histopathologic extent of embolic infarction. In the CSF from rabbits with experimentally induced stroke, PGF^ was the predominant and most elevated prostaglandin. We also found an increased level of PGE, and a smaller increase in PGD 2 . As our preliminary data was derived from pooled samples, no attempt was made to test the null hypothesis.
In rat and gerbil brain, ischemic insult is followed by marked increases in PGD 2 as well as in PGF^ and PGEj. 23 - 27 In ischemic canine brain, increases in PGF 2 , PGEj, and prostacyclin have been found.
1416
- 26 In studies of human and canine CSF, PGF^ shows the greatest increase after ischemic insult to brain.
PGF^ is a potent mediator of cerebral vascular constrict ion, U4 -29 - 30 and the elevation of this metabolite during ischemia may reflect increased activity of PGEj-9-keto reductase 24 or nonenzymatic reduction by biogenic amines. 2531 Our preliminary study determined the CSF prostaglandin concentrations in normal rabbits and in rabbits rendered focalry ischemic. The changes observed in the focalry ischemic rabbits subjected to embolic infarction are consistent with previous reports of CSF prostaglandins in both human and canine central nervous system ischemia. 1416 It may be advantageous to study more immediate postischemic prostaglandin changes in CSF as prostanoid levels have been shown to fluctuate during reperfusion of ischemic brain. 23 - 32 This experimental model allows study of more immediate postischemic prostaglandin changes in CSF rather than whole brain and may be appropriate for further study of the role and prognostic value of prostaglandins in stroke.
